AZN.L

AstraZeneca PLC [AZN.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

AZN.L Stock Summary

Top 10 Correlated ETFs

AZN.L


Top 10 Correlated Stocks

AZN.L


In the News

AZN.L Financial details

Company Rating
Strong Buy
Market Cap
162.49B
Income
5.96B
Revenue
45.81B
Book val./share
25.27
Cash/share
3.78
Dividend
2.35
Dividend %
1.7%
Employees
89.9K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
36.31
Forward P/E
1289.61
PEG
4.5
P/S
4.76
P/B
5.76
P/C
2824.87
P/FCF
30.71
Quick Ratio
0.18
Current Ratio
0.79
Debt / Equity
0.73
LT Debt / Equity
0.59
-
-
EPS (TTM)
3.83
EPS next Y
8.28
EPS next Q
1.92
EPS this Y
81.13%
EPS next Y
116.29%
EPS next 5Y
212.17%
EPS last 5Y
30.11%
Revenue last 5Y
13.44%
Revenue Q/Q
4.63%
EPS Q/Q
-31.46%
-
-
-
-
SMA20
2.69%
SMA50
-2.63%
SMA100
1.5%
Inst Own
0%
Inst Trans
0%
ROA
6%
ROE
16%
ROC
0.1%
Gross Margin
80%
Oper. Margin
15%
Profit Margin
13%
Payout
76%
Shs Outstand
1.55B
Shs Float
1.47B
-
-
-
-
Target Price
-
52W Range
9461.0-12392.0
52W High
-13.83%
52W Low
+12.86%
RSI
64
Rel Volume
0.44
Avg Volume
2.93M
Volume
1.28M
Perf Week
4.4%
Perf Month
8.67%
Perf Quarter
-1.64%
Perf Half Y
-4.61%
-
-
-
-
Beta
0.173
-
-
Volatility
176.98%, 182.22%
Prev Close
-0.6%
Price
10678
Change
2.08%

AZN.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
18.7420.2926.3928.6529.57
Net income per share
1.032.440.082.123.84
Operating cash flow per share
2.283.664.216.346.68
Free cash flow per share
0.391.672.654.684.24
Cash per share
4.786.094.514.143.78
Book value per share
10.0911.9127.6923.9325.27
Tangible book value per share
-13.76-13.07-16.29-14.26-12.25
Share holders equity per share
10.0911.9127.6923.9325.27
Interest debt per share
15.1116.5322.6219.7519.5
Market cap
129.78B130.98B166.1B210.12B208.99B
Enterprise value
142.63B143.53B190.55B233.19B231.77B
P/E ratio
97.2140.981.48K63.9135.09
Price to sales ratio
5.324.924.444.744.56
POCF ratio
43.7127.2927.8621.4220.2
PFCF ratio
254.9659.7344.1429.0331.82
P/B Ratio
9.898.384.235.675.34
PTB ratio
9.898.384.235.675.34
EV to sales
5.855.395.095.265.06
Enterprise value over EBITDA
20.3317.1525.192516.66
EV to operating cash flow
48.0429.9131.9623.7822.4
EV to free cash flow
280.2265.4550.6432.2235.29
Earnings yield
0.010.0200.020.03
Free cash flow yield
00.020.020.030.03
Debt to equity
1.391.30.780.790.73
Debt to assets
0.30.310.290.30.28
Net debt to EBITDA
1.831.53.232.471.64
Current ratio
0.860.961.160.860.82
Interest coverage
2.043.950.812.795.16
Income quality
1.921.23-22.53.921.5
Dividend Yield
0.030.030.020.020.02
Payout ratio
2.691.1234.431.330.75
Sales general and administrative to revenue
00000
Research and developement to revenue
0.240.230.260.220.24
Intangibles to total assets
0.530.490.590.610.57
Capex to operating cash flow
-0.83-0.54-0.37-0.26-0.37
Capex to revenue
-0.1-0.1-0.06-0.06-0.08
Capex to depreciation
-0.65-0.83-0.34-0.47-0.77
Stock based compensation to revenue
0.010.010.020.010
Graham number
15.2625.557.0233.8146.75
ROIC
0.070.11-0.010.070.1
Return on tangible assets
0.050.0900.090.14
Graham Net
-27.88-29.14-33.23-29.24-34.46
Working capital
-2.55B-763M3.65B-3.7B-5.49B
Tangible asset value
-17.91B-17.15B-23.1B-22.07B-18.97B
Net current asset value
-31.22B-31.55B-39.83B-36.83B-36.9B
Invested capital
1.391.30.780.790.73
Average receivables
1.73B3.7B7.28B8.99B3.61B
Average payables
13.41B14.89B17.36B18.99B11.15B
Average inventory
3.04B3.61B6.5B6.84B5.06B
Days sales outstanding
53.6652.19104.9459.350
Days payables outstanding
1.04K1.09K555.79560.86144.23
Days of inventory on hand
236.83277.18263.63138.42239.45
Receivables turnover
6.86.993.486.150
Payables turnover
0.350.340.660.652.53
Inventory turnover
1.541.321.382.641.52
ROE
0.10.200.090.15
Capex per share
-1.89-1.99-1.55-1.66-2.44

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
7.237.027.377.427.76
Net income per share
0.581.161.170.890.62
Operating cash flow per share
1.552.021.112.011.54
Free cash flow per share
1.191.070.81.440.93
Cash per share
4.134.173.753.33.78
Book value per share
23.9123.124.1224.0125.27
Tangible book value per share
-14.25-15.16-13.46-13.17-12.25
Share holders equity per share
23.9123.124.1224.0125.27
Interest debt per share
19.120.5719.5318.718.74
Market cap
210.26B215.52B220.22B207.85B208.99B
Enterprise value
233.32B240.79B244.39B231.56B231.77B
P/E ratio
58.3429.8830.2837.8254.42
Price to sales ratio
18.7619.8119.2918.0917.38
POCF ratio
87.6868.79128.1866.7587.81
PFCF ratio
114.02129.6178.3293145.74
P/B Ratio
5.686.025.895.595.34
PTB ratio
5.686.025.895.595.34
EV to sales
20.8222.1321.4120.1519.28
Enterprise value over EBITDA
205.0361.9397.0269.6279.67
EV to operating cash flow
97.376.86142.2674.3697.38
EV to free cash flow
126.53144.79197.89103.6161.62
Earnings yield
00.010.010.010
Free cash flow yield
0.010.010.010.010.01
Debt to equity
0.790.880.80.770.73
Debt to assets
0.30.330.310.30.28
Net debt to EBITDA
20.276.59.67.137.83
Current ratio
0.860.90.870.790.82
Interest coverage
-0.956.985.74.983.02
Income quality
3.081.390.821.882.65
Dividend Yield
00.0100.010
Payout ratio
01.690.011.030
Sales general and administrative to revenue
00.370.440.42-1.15
Research and developement to revenue
0.230.240.230.220.26
Intangibles to total assets
0.610.610.60.60.57
Capex to operating cash flow
-0.23-0.47-0.28-0.28-0.4
Capex to revenue
-0.05-0.14-0.04-0.08-0.08
Capex to depreciation
-0.37-0.98-0.38-0.69-1.08
Stock based compensation to revenue
0.060000
Graham number
17.6924.625.2321.8918.77
ROIC
-0.010.030.030.020.02
Return on tangible assets
0.020.050.050.040.02
Graham Net
-29.22-28.54-27.4-27.52-34.46
Working capital
-3.7B-2.59B-3.54B-6.09B-5.49B
Tangible asset value
-22.07B-23.48B-20.87B-20.41B-18.97B
Net current asset value
-36.83B-38.61B-36.29B-36.36B-36.9B
Invested capital
0.790.880.80.770.73
Average receivables
8.69B8.75B10.69B11.2B5.65B
Average payables
18.37B19.13B19.47B20.14B11.9B
Average inventory
4.89B4.83B5.01B5.17B5.36B
Days sales outstanding
57.9285.1287.4588.50
Days payables outstanding
590.9907.56906.34882.47127.4
Days of inventory on hand
145.83234.66231.93227.34211.51
Receivables turnover
1.551.061.031.020
Payables turnover
0.150.10.10.10.71
Inventory turnover
0.620.380.390.40.43
ROE
0.020.050.050.040.02
Capex per share
-0.36-0.95-0.31-0.57-0.61

AZN.L Frequently Asked Questions

What is AstraZeneca PLC stock symbol ?

AstraZeneca PLC is a GB stock and trading under the symbol AZN.L

What is AstraZeneca PLC stock quote today ?

AstraZeneca PLC stock price is $10678 today.

Is AstraZeneca PLC stock public?

Yes, AstraZeneca PLC is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks